Moderna: 'Our concern is more in valuation' with booster shots 'baked into the stock,' analyst says

Retrieved on: 2021-12-29 18:57:38

Tags for this article:

Click the tags to see associated articles and topics

Moderna: 'Our concern is more in valuation' with booster shots 'baked into the stock,' analyst says. View article details on hiswai:

Excerpt

The mRNA technology was quite effective and very rapid to generate a highly effective vaccine in spike backs. And I think the company has done a ...

Article found on: finance.yahoo.com